Pelthos Pharmaceuticals
Pitch Summary: Pelthos Pharmaceuticals has launched Zelsuvmi, the first FDA-approved at-home treatment for molluscum contagiosum, showing strong initial sales and growth potential in a large market. BSD Analysis: Pelthos Pharmaceuticals has demonstrated a promising start with its lead drug, Zelsuvmi, achieving $7.1 million in net revenue in its first quarter of commercialization. The company is […]
